Literature DB >> 33958344

Thrombotic thrombocytopenia due to SARS-CoV-2 vaccination.

Keith R McCrae1.   

Abstract

Vaccine-induced thrombotic thrombocytopenia (VITT) has been reported after vaccination with the AztraZeneca ChAdOx1 nCoV-19 and the Johnson and Johnson Ad26. COV2.S vaccines. This manuscript provides a brief overview of reported cases, clinical and laboratory features, and current understanding of the pathogenesis of VITT. The author also poses unananswered questions and identifies directions for future study.
Copyright © 2021 The Cleveland Clinic Foundation. All Rights Reserved.

Entities:  

Year:  2021        PMID： 33958344     DOI： 10.3949/ccjm.88a.ccc078

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  9 in total

Review 1.  Relationship between blood clots and COVID-19 vaccines: A literature review.

Authors:  Seyed Mohammad Hassan Atyabi; Foad Rommasi; Mohammad Hossein Ramezani; Mohammad Fazel Ghane Ezabadi; Mehdi AghaAmooi Arani; Mohammad Hossein Sadeghi; Mohammad Mehdi Ahmed; Amir Rajabi; Nima Dehghan; Ali Sohrabi; Mojtaba Seifi; Mohammad Javad Nasiri
Journal:  Open Life Sci       Date:  2022-04-26       Impact factor: 1.311

2.  Vaccine-induced immune thrombocytopaenia and thrombosis (VITT) after COVID-19 vaccination.

Authors:  Maria Inês Ribeiro; Inês Pimenta; Inês Conde; Filipe André Gonzalez
Journal:  BMJ Case Rep       Date:  2022-05-19

3.  Selective COVID-19 Coinfections in Diabetic Patients with Concomitant Cardiovascular Comorbidities Are Associated with Increased Mortality.

Authors:  Kamaleldin B Said; Ahmed Alsolami; Fawwaz Alshammari; Fayez Saud Alreshidi; Anas Fathuldeen; Fawaz Alrashid; Abdelhafiz I Bashir; Sara Osman; Rana Aboras; Abdulrahman Alshammari; Turki Alshammari; Sultan F Alharbi
Journal:  Pathogens       Date:  2022-04-25

4.  Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.

Authors:  Elsa V C Rodriguez; Fatima-Zohra Bouazza; Nicolas Dauby; François Mullier; Stéphanie d'Otreppe; Patrice Jissendi Tchofo; Magali Bartiaux; Camille Sirjacques; Alain Roman; Cédric Hermans; Manuel Cliquennois
Journal:  Infection       Date:  2021-10-09       Impact factor: 7.455

Review 5.  Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective.

Authors:  Abid A Haseeb; Omar Solyman; Mokhtar M Abushanab; Ahmed S Abo Obaia; Abdelrahman M Elhusseiny
Journal:  Vaccines (Basel)       Date:  2022-02-21

6.  Refined Capsid Structure of Human Adenovirus D26 at 3.4 Å Resolution.

Authors:  Vijay S Reddy; Xiaodi Yu; Michael A Barry
Journal:  Viruses       Date:  2022-02-17       Impact factor: 5.048

7.  ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome.

Authors:  Alexander T Baker; Ryan J Boyd; Daipayan Sarkar; Alicia Teijeira-Crespo; Chun Kit Chan; Emily Bates; Kasim Waraich; John Vant; Eric Wilson; Chloe D Truong; Magdalena Lipka-Lloyd; Petra Fromme; Josh Vermaas; Dewight Williams; LeeAnn Machiesky; Meike Heurich; Bolni M Nagalo; Lynda Coughlan; Scott Umlauf; Po-Lin Chiu; Pierre J Rizkallah; Taylor S Cohen; Alan L Parker; Abhishek Singharoy; Mitesh J Borad
Journal:  Sci Adv       Date:  2021-12-01       Impact factor: 14.136

8.  The Frequency and Patterns of Post-COVID-19 Vaccination Syndrome Reveal Initially Mild and Potentially Immunocytopenic Signs in Primarily Young Saudi Women.

Authors:  Kamaleldin B Said; Amal Al-Otaibi; Luluh Aljaloud; Basmah Al-Anazi; Ahmed Alsolami; Fayez Saud Alreshidi
Journal:  Vaccines (Basel)       Date:  2022-06-24

9.  COVID-19 vaccine acceptance among high-risk populations in Uganda.

Authors:  Felix Bongomin; Ronald Olum; Irene Andia-Biraro; Frederick Nelson Nakwagala; Khalid Hudow Hassan; Dianah Rhoda Nassozi; Mark Kaddumukasa; Pauline Byakika-Kibwika; Sarah Kiguli; Bruce J Kirenga
Journal:  Ther Adv Infect Dis       Date:  2021-06-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.